Schedule 13G ownership disclosure

INOVIO PHARMACEUTICALS INC

Common Stock · CUSIP: 45773H409

Event date: 2025-03-31

Filing-level shares
2,028,959
Percent of class
5.53%
  • The Vanguard Group

    Shares: 2,028,959 · Class: 5.53%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000647
Form type
SCHEDULE 13G
Filer
INOVIO PHARMACEUTICALS, INC.
CIK
CIK 1055726
Filed
Apr 30, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub